Código QR (código de barras bidimensional)

Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy

Introduction: In classical Hodgkin lymphoma (cHL), the delayed effects of therapies, such as second malignancies and toxicity, and the high relapse rate are potentially associated with an expense for the National Health Service (NHS). Objective: The objective of the study was to estimate the impact...

Fuld beskrivelse

Na minha lista:
Principais autores: Francesca Fiorentino, Chiara Vassallo, Beatrice Canali, Paolo Morelli, Silvia Ripoli, Laura Fioravanti
Format: Artigo
Sprog:Inglês
Udgivet: AboutScience Srl 2023-10-01
Serier:AboutOpen
Fag:
Brentuximab vedotin
Cost analysis
Economic analysis
Hodgkin lymphoma
Italy
Online adgang:https://journals.aboutscience.eu/index.php/aboutopen/article/view/2609
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker